Key stats
About VANECK UCITS ETFS PLC GENOMICS & HEALTHCARE INNOVATORS UCITS E
Expense ratio
0.35%
Home page
Inception date
Sep 2, 2022
ISIN
IE000B9PQW54
The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Technology Services
Stocks99.99%
Health Technology77.17%
Technology Services11.20%
Health Services8.35%
Commercial Services1.72%
Distribution Services0.74%
Retail Trade0.42%
Electronic Technology0.38%
Bonds, Cash & Other0.01%
Cash0.01%
Stock breakdown by region
North America89.58%
Asia5.91%
Europe2.55%
Oceania1.96%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history